These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1439 related items for PubMed ID: 26012153

  • 1. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I, Sladoje-Martinović B, Orlić L, Milić S, Lukenda V, Župan Ž, Štimac D, Rački S.
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [Abstract] [Full Text] [Related]

  • 2. Viral hepatitis in solid organ transplantation other than liver.
    Vallet-Pichard A, Fontaine H, Mallet V, Pol S.
    J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
    [Abstract] [Full Text] [Related]

  • 3. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus and nonliver solid organ transplantation.
    Carbone M, Mutimer D, Neuberger J.
    Transplantation; 2013 Mar 27; 95(6):779-86. PubMed ID: 23172130
    [Abstract] [Full Text] [Related]

  • 5. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E, Strasser SI, Koorey DJ, Verran D, McCaughan GW.
    Clin Transplant; 2006 Mar 27; 20(3):369-73. PubMed ID: 16824156
    [Abstract] [Full Text] [Related]

  • 6. Management of chronic viral hepatitis before and after renal transplantation.
    Gane E, Pilmore H.
    Transplantation; 2002 Aug 27; 74(4):427-37. PubMed ID: 12352899
    [Abstract] [Full Text] [Related]

  • 7. Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
    Bohorquez HE, Cohen AJ, Girgrah N, Bruce DS, Carmody IC, Joshi S, Reichman TW, Therapondos G, Mason AL, Loss GE.
    Liver Transpl; 2013 Jun 27; 19(6):611-8. PubMed ID: 23526668
    [Abstract] [Full Text] [Related]

  • 8. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD, Feng SJ, Liu JP, Song TR, Huang ZL, Fan Y, Shi YY, Chen LY, Lv YH, Xu ZL, Li XH, Wang L, Lin T.
    BMC Infect Dis; 2021 Jan 09; 21(1):41. PubMed ID: 33422017
    [Abstract] [Full Text] [Related]

  • 9. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
    Chancharoenthana W, Townamchai N, Pongpirul K, Kittiskulnam P, Leelahavanichkul A, Avihingsanon Y, Suankratay C, Wattanatorn S, Kittikowit W, Praditpornsilpa K, Tungsanga K, Eiam-Ong S.
    Am J Transplant; 2014 Dec 09; 14(12):2814-20. PubMed ID: 25395260
    [Abstract] [Full Text] [Related]

  • 10. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
    Madayag RM, Johnson LB, Bartlett ST, Schweitzer EJ, Constantine NT, McCarter RJ, Kuo PC, Keay S, Oldach DW.
    Transplantation; 1997 Dec 27; 64(12):1781-6. PubMed ID: 9422420
    [Abstract] [Full Text] [Related]

  • 11. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
    Natov SN, Pereira BJ.
    Transpl Infect Dis; 2002 Sep 27; 4(3):117-23. PubMed ID: 12421455
    [Abstract] [Full Text] [Related]

  • 12. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A, Pol S.
    Nephrol Ther; 2015 Nov 27; 11(6):507-20. PubMed ID: 26423779
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P, Rodríguez-Castro KI, Marchini F, Bonfante L, Furian L, Ferrarese A, Zanetto A, Germani G, Russo FP, Senzolo M.
    Transpl Int; 2014 Sep 27; 27(9):877-91. PubMed ID: 24853721
    [Abstract] [Full Text] [Related]

  • 14. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
    Yilmaz VT, Aliosmanoglu I, Erbis H, Ulger BV, Cetinkaya R, Suleymanlar G, Kocak H.
    Transpl Infect Dis; 2016 Feb 27; 18(1):55-62. PubMed ID: 26565663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis B in renal transplant patients.
    Marinaki S, Kolovou K, Sakellariou S, Boletis JN, Delladetsima IK.
    World J Hepatol; 2017 Sep 08; 9(25):1054-1063. PubMed ID: 28951777
    [Abstract] [Full Text] [Related]

  • 17. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.
    Clin Transplant; 2011 Sep 08; 25(1):E77-81. PubMed ID: 21039887
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
    Yuan CH, Liu YF, Li GC.
    Chin Med Sci J; 2005 Jun 08; 20(2):129-32. PubMed ID: 16075755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.